Pharma Pulse 3/5/25: Tariff Impact on Medication Availability/Accessibility for Telehealth Patients, Addressing the Gap in Type 1 Diabetes Care & more

Potential Tariff Impact on Availability & Accessibility of Medications for Telehealth Patients

In this Pharmaceutical Executive Video Interview, Peter Ax, Founder & CEO of UpScriptHealth, discusses the impact of tariffs on the pharmaceutical industry, highlighting that tariffs will initially affect pharmaceutical companies, particularly those dealing with branded medications and generics. He notes that tariffs could lead to strategic supply chain changes, including potential US manufacturing shifts. Digital health platforms like UpScriptHealth aim to reduce friction and costs in healthcare, potentially offsetting tariff impacts. Ax emphasizes the importance of telehealth in ensuring medication availability and the strategic partnerships between digital health platforms and pharma companies to improve patient care and access. He also praises Pfizer's approach to delivering comprehensive care rather than just selling medications.

Addressing the Gap in Type 1 Diabetes Care with Personalized Coaching and Education

Arti Masturzo, M.D., chief medical officer of CCS, spoke with Managed Healthcare Executive about the differences in coaching and guiding patients with type 1 diabetes compared to type 2.

TSMC, the Chip Giant, Is to Spend $100 Billion in U.S. Over the Next 4 Years

The investment plan, announced at the White House, was made as the Trump administration pushes to bring chip making back to the United States.

Medable Achieves CNIL Approval, Expanding Access for Digital Clinical Trials Across the European Union

Medable Inc. has announced that its eConsent and eCOA solutions have been approved for use in two clinical studies in eight countries outside of the European Union by France’s Commission Nationale de l’Informatique et des Libertés (CNIL). This makes Medable uniquely capable of operating as a data processor outside of the CNIL MR-001 Reference Methodology requirements for a France-based clinical trial sponsor.

Jon Paul Pedigo-Gomez on LinkedIn

Great read. Thanks for sharing Pharmaceutical Commerce Magazine

Have news you want us to share in Pharma Pulse? Reach out to Editor Miranda Schmalfuhs